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Abstract
Quantifying the dynamics of intrahost HIV-1 sequence evolution is one means of uncovering information about the
interaction between HIV-1 and the host immune system. In the chronic phase of infection, common dynamics of sequence
divergence and diversity have been reported. We developed an HIV-1 sequence evolution model that simulated the effects
of mutation and fitness of sequence variants. The amount of evolution was described by the distance from the founder
strain, and fitness was described by the number of offspring a parent sequence produces. Analysis of the model suggested
that the previously observed saturation of divergence and decrease of diversity in later stages of infection can be explained
by a decrease in the proportion of offspring that are mutants as the distance from the founder strain increases rather than
due to an increase of viral fitness. The prediction of the model was examined by performing phylogenetic analysis to
estimate the change in the rate of evolution during infection. In agreement with our modeling, in 13 out of 15 patients
(followed for 3–12 years) we found that the rate of intrahost HIV-1 evolution was not constant but rather slowed down at a
rate correlated with the rate of CD4+ T-cell decline. The correlation between the dynamics of the evolutionary rate and the
rate of CD4+ T-cell decline, coupled with our HIV-1 sequence evolution model, explains previously conflicting observations
of the relationships between the rate of HIV-1 quasispecies evolution and disease progression.
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Introduction
Within an HIV-1 infected individual, the HIV-1 population
evolves under host immune response selection pressures [1–3].
Development of genetic diversity within the host results from a
high virus replication error frequency (3.4610
25 mutations
site
21generation
21 [4]) coupled with an in vivo virus production
rate exceeding 10
10 virions per day [5]. Both diversifying and
purifying selection impact the evolution of HIV-1 sequences. In
the absence of antiretroviral drug treatment, HIV-1 must balance
the preservation of important life cycle functions with the ability to
escape host immune surveillance.
The interaction between the HIV-1 population and the host is
revealed in the following observations: First, an increase of fitness
during the course of chronic infection has been demonstrated by
comparing the replication rate of virus genomes isolated at early
times following infection with that of later viruses [6]. Second,
although CD8+ T-lymphocytes restrain virus replication in HIV-1
infection, escapes from both CD8+ T-cell responses and
neutralizing antibodies are well documented [7–9]. Studies on
CD8+ T-cell response to autologous virus Env, Gag, and Tat
proteins observed variation at epitope-containing sites in the HIV-
1 population [10,11]. Such variation implies escape from CD8+
T-cell responses. Furthermore, changes in N-linked glycosylation
sites in Env have been observed in viruses that escape antibody
neutralization [12].
Two measures have been used to describe HIV-1 evolution
quantitatively, diversity, the genetic variation at a given time, and
divergence, the genetic distance to a reference point, usually the
founder virus. While several studies have investigated these
measures, a detailed study carried out by Shankarappa et al.
followed 9 patients longitudinally over 10–15 years [13]. They
found that in the first phase of the asymptomatic period, both viral
divergence and diversity increased linearly in the C2-V5 region of
env. In a second phase, the viral population continued to diverge
from the founder strain at the same rate, while diversity started to
plateau or constrict. In the final phase, divergence stabilized and
diversity declined. The decline of diversity was associated with the
emergence of viruses using the CXCR4 coreceptors, expressed on
both memoryand naive cells, more soon naive T cells [14–17]. The
stabilization of nonsynonymous divergence was reported to be more
pronounced than the synonymous divergence at the late stage of
infection [18,19], suggesting reduced immune selective pressure.
The rate of intrahost HIV-1 sequence evolution has been
correlated with the progression of the disease, which shows a
considerable variability among patients (from a few months to 20 or
more years). Several studies have found an inverse relationship
between the rate of viral diversification and the host disease
progression rate [1,2,18,20–22], while others have not [23,24]. In
addition, it has been suggested that the level of genetic diversity that
can be controlled by the host immune system is limited, and that
exceeding a diversity threshold may be a key factor for disease
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between the synonymous substitution rate of HIV-1 and disease
progression parameters [19]. Subjects with moderate disease
progression from Shankarappa et al. [13] displayed a faster rate of
synonymous substitutions in comparison to subjects with slow
disease progression. It was speculated that a longer viral generation
time may be responsible for a slower rate of synonymous
substitutions and slower disease progression.
To unify all these observations, i.e., the universal intrahost
dynamics of divergence and diversity and the contradicting
observations between the rate of disease progression and the rate
of intrahost evolution, here we propose a simple sequence evolution
model that includes a mutation probability and a fitness value of
sequence variants. Themodelaccuratelydescribed HIV-1sequence
evolution within a patient, reflecting the dynamics of divergence
and diversity over the infection by suggesting a slowdown of the
evolutionary rate as disease progresses. We then measured the
dynamicsof intrahost HIV-1 sequence evolution from 15 previously
followed patients and linked the change in the evolutionary rate to
the dynamics of the CD4+ T-cell count. Deciphering the dynamics
of intrahost HIV-1 quasispecies evolution allowed us to explain
previously reported contrasting relationships between the speed of
HIV-1 quasispecies evolution and disease progression.
Results
Sequence Evolution Model
To interpret the common dynamics of the divergence and
diversity within a host in the chronic phase of HIV-1 infection, we
developed a sequence evolution model where each viral sequence
is represented by its distance to the founder strain, d. In this model,
the number of sequences, N(d,t), at a distance d from the founder
strain at time t is dictated by two factors: 1) the fitness, F(d), defined
as the total number of offspring sequences from sequence d
generated per unit time; and 2) the probability, M(d), of sequence d
to evolve to sequence d+1 per unit time. Here we assume that the
unit of time is chosen such that the probability of evolving to
distances greater than d+1 in one time unit is negligible.
As shown in Figure 1A, at time 0, the total number of copies of
virus 0 is N(0,0). At time 1, the total number of offspring sequences
from virus 0 is F(0)N(0,0). Out of this total number of offspring, the
number of mutant sequences is F(0)N(0,0)M(0), and the number of
non-mutant sequences is F(0)N(0,0)(12M(0)). Hence M(d) denotes
the proportion of offspring that are mutants. In general form, this
process is expressed as
Nd ,t ðÞ ~Fd ðÞ Nd ,t{1 ðÞ 1{Md ðÞ ðÞ
zFd {1 ðÞ Nd {1,t{1 ðÞ Md {1 ðÞ :
ð1Þ
Author Summary
Saturation of sequence divergence and a decline of
diversity in later stages of infection have been commonly
observed during HIV-1 infection, although the length of
the time to acquired immunodeficiency syndrome (AIDS) is
highly variable among patients. To explain this common
feature, we developed a simple sequence evolution model
with two main components: (i) fitness, the number of
offspring produced, and (ii) the proportion of offspring
that are mutants. Assuming a decrease in the proportion
of offspring that are mutants as virus variants evolve
further from the founder strain, we were able to fit the
universal trends of divergence and diversity. In contrast,
neither the model with gradual increase of fitness nor the
model with rapid emergence of virus variants with greater
fitness explained the dynamics of divergence and diversity.
The prediction of the model was confirmed in the majority
of longitudinally followed patients; the rate of HIV-1
evolution was stationary before disease progresses;
however, the rate slowed down at a rate correlated with
the rate of immune cell decline. Deciphering dynamic
correlation between the rate of HIV-1 evolution and the
kinetics of immune cell level united previous conflicting
observations of the relationships between the rate of HIV-1
evolution and disease progression.
Figure 1. Schematic diagram of the HIV-1 sequence evolution
model. (A) Each sequence is represented with a sequence index, d (the
number within the circle), equal to the distance from the founder strain.
N(d,t) denotes the total number of sequences at distance d at time t.
F(d) is the total number of sequences produced per unit time per
sequence. A sequence d at time t generates either sequence d+1 with
probability M(d) by a mutation, or sequence d with probability 12M(d)
at time t+1. M(d) is the proportion of offspring that are mutants. (B) The
divergence is defined as the mean and the diversity is defined as the
standard deviation of the distribution of P(d,t) in Eq. (2). The position of
the mean (divergence) is shown as the vertical line of each P(d,t) at year
1, 4, and 10, respectively. The standard deviation (diversity) is shown as
the horizontal line of each distribution. (C) The profile of M(d) for the
general (full) sequence evolution model (left panel), submodel 1
(middle panel), and submodel 2 (right panel). Here ds denotes the
distance from which M(d) starts to decline and dmax denotes the
distance point of M(d)=0.
doi:10.1371/journal.pcbi.1000240.g001
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over time. Rather than a simple Hamming distance, which for
finite sequence lengths cannot grow at a constant rate, the genetic
distance we emulate is the distance realistic substitution models
attempt to estimate [26–28]. In our later tree analyses of real data,
we have used a general-time-reversible model that includes rate
variation across sites that has been shown to realistically describe
HIV-1 nucleotide evolution [26,29]. We show below that the
evolutionary rate of the 15 patients we analyze is approximately
10
23 per site per month. Since we analyze about a 600 nucleotide
region of the HIV-1 env gene, this implies that we expect less than
one substitution per month. Thus, a time unit of approximately
one month is appropriate to analyze this data. Thus, our model is
not following all the point mutations that can occur due to reverse
transcription but rather simulates the growth of the true genetic
distance from the founder in the presence of selection. In reality,
multiple variants can exist at the same distance from the founder
strain. In our model those variants have the same identification
index, d, the distance from the founder strain and this implies that
we need a measure of diversity that does not rely directly on
sequence information but rather on the distribution of genetic
distances d.
Since an approximately constant number of sequences were
sampled at all time points [13], we consider the normalized
distribution of the distances at time t, i.e.,
Pd ,t ðÞ ~Nd ,t ðÞ
,
X ?
d~0
Nd ,t ðÞ : ð2Þ
The divergence Ddivergence(t), i.e., the average number of nucleotide
substitutions that accumulated along the branch from the founder
strain as a function of time [13], is measured by the mean value of
d, i.e.,
Ddivergence t ðÞ ~
X ?
d~0
Pd ,t ðÞ d, ð3Þ
(Figure 1B). The diversity Ddiversity(t), measured by Shankarappa et
al. [13] as the average pairwise nucleic acid distance between all
sequences at time t, is here measured with the standard deviation
of P(d,t)a s
Ddiversity t ðÞ ~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
X ?
d~0
Pd ,t ðÞ d2{
X ?
d~0
Pd ,t ðÞ d
 ! 2
v u u t , ð4Þ
(Figure 1B). In our model, because we do not discriminate between
the variants at the same distance, we measure the level of diversity
with the level of spread in the distance from the founder strain.
This measure is an approximation made for consistency with our
modeling approach. To examine this approximation, we calculat-
ed the measure of genetic diversity at the nucleotide level used by
Shankarappa et al. and the measure of the standard deviation of
the distance distribution from the founder strain, Eq. (4), for the
same data in [13]. The two measures were found to be
proportional to each other (Figure 2).
We assumed that the probability of mutation varied as a
function of the distance from the original strain, d, according to
M(d)=m if d#ds, m(dmax2d)/(dmax2ds)i fds,d,dmax, and M(d)=0
if d$dmax, where m is a constant, ds is the starting point (distance)
for the decline of M(d), and dmax is the distance at which M(d)=0
(left panel in Figure 1C). The profile of M(d) directly reflects the
retardation in the rate of sequence evolution as the virus evolves
further from the founder strain.
To observe the effect of the profile of M(d) (left panel in
Figure 1C) on the macroscopic evolution patterns, we first fixed
the fitness as a constant, F(d)=f. Figure 3 shows the fit of the model
to the dynamics of divergence and diversity of patients S-P1—S-
P11 [13]. The fit of the model is summarized in Table 1. The
method of calculating divergence and diversity dynamics is
provided in Materials and Methods. Encouragingly, our model
successfully quantified the dynamics of the divergence and the
diversity based on first a constant evolutionary rate, then followed
by a decline of the evolutionary rate (left panel in Figure 1C).
Special Cases of the Sequence Evolution Model
To further investigate the relationship between the profile of
M(d) and the dynamics of divergence and diversity, we studied two
special cases of M(d) in greater detail. Submodel 1 is defined by
M(d) equal to a constant, m (middle panel in Figure 1C). For a
constant fitness, F(d)=f, the normalized distribution of the distance
at time t, P(d,t), satisfies
LPd ,t ðÞ
Lt
~{mP d,t ðÞ zmP d{1,t ðÞ , ð5Þ
with P(d,0)=1 if d=0 and P(d,0)=0 otherwise. The generating
function, Fz ,t ðÞ ~
P ?
d~0
Pd ,t ðÞ zd, satisfies the following equation,
LFz ,t ðÞ
Lt
~{mF z,t ðÞ zmzF z,t ðÞ , ð6Þ
with F(z,0)=1. The solution of Eq. (6) is given by F(z,t)=e
m(z21)t.
This implies that P(d,t) is a Poisson distribution, P(d,t)=e
2mt(mt)
d/
d!. The mean of this distribution gives the divergence,
Figure 2. Two measures of diversity dynamics of 9 longitudi-
nally followed patients. Diversity dynamics of each subject from the
definition of average pairwise distance [red line] among all the
sequences sampled at the same time point and the standard deviation
[blue line] of the distribution of the tree distances of all the sequences
at the same time point from the founder strain multiplied by a constant
factor. The constant factors are 20, 20, 25, 25, 27, 40, 40, 30, 70 for S-P1
to S-P11, respectively. The two measures of diversity are proportional to
each other.
doi:10.1371/journal.pcbi.1000240.g002
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Ddiversity t ðÞ ~
ﬃﬃﬃﬃﬃﬃ
mt
p
. In this special case, both divergence and
diversity increase as a function of time rather than saturate or
decrease at later time points. Thus, assuming a constant fitness and
constant evolutionary rate over the period of chronic infection fails
to describe well the simultaneous intrahost dynamics of divergence
and diversity. The fit of submodel 1 to the divergence and the
diversity dynamics in all 9 patients is summarized in Table 1.
In submodel 2, we set ds=0, resulting in a linear decrease of the
probability of accumulated mutations per unit time, given by
M(d)=(12d/dmax) for d#dmax and M(d)=0 for d.dmax (right panel
in Figure 1C). In this case, from Eqs. (1) and (2), the dynamics of
the evolution is summarized as
LPd ,t ðÞ
Lt
~
d
dmax
{1
  
Pd ,t ðÞ z 1{
d{1 ðÞ
dmax
  
Pd {1,t ðÞ , ð7Þ
for d#dmax and hP(d,t)/ht=0 for d.dmax.
Now the generating function Fz ,t ðÞ ~
P ?
d~0
Pd ,t ðÞ zd satisfies
LFz ,t ðÞ
Lt
~ z{1 ½  Fz ,t ðÞ z
z
dmax
1{z ½ 
LF
Lz
, ð8Þ
with F(z,0)=1 from P(d,0)=1 when d=0 and P(d,0)=0 otherwise.
This equation can be solved using the method of characteristics.
Let z and t be the functions of s. Then F(z,t)=F(z(s),t(s))=F(s) and
dF
ds
~
dt
ds
LF
Lt
z
dz
ds
LF
Lz
: ð9Þ
If we choose the characteristic curve such that
dt
ds
~1, ð10Þ
with t(s=0)=0, we have t=s. By comparing Eq. (8) with (9), we
obtain
dz
ds
~
z 1{z ðÞ
dmax
: ð11Þ
By integrating Eq. (11), we have
zs ðÞ ~
z 0 ðÞ
z 0 ðÞ z 1{z 0 ðÞ ½  exp s=dmax ðÞ
: ð12Þ
Along this characteristic curve, by inserting Eqs. (8), (10) and (11)
into Eq. (9), we obtain
dF
ds
~ zs ðÞ {1 ½  Fs ðÞ : ð13Þ
By integrating Eq. (13), we obtain
Fs ðÞ ~ z 0 ðÞ z 1{z 0 ðÞ ðÞ exp s=dmax ðÞ ½ 
{dmax, ð14Þ
Figure 3. The fit of the full model to dynamics of divergence
and diversity. Dynamics of divergence and diversity fitted with the
full model (right panel in Figure 1C). We calculated divergence by first
measuring the tree distance between a sequence sampled at time t and
a strain found at the initial sample time point. Then we averaged all the
pairwise tree distances between the sequences at t and the sequence
sampled at the earliest time point. Likewise, the diversity was calculated
from the data by averaging pairwise tree distances over all the
sequences obtained at time t. We fixed parameters as m=0.9 and f=1
estimated ds and dmax using a non-linear least squares method based
on the Levenberg-Marquardt algorithm [59] and calculated 95% C.I. of
these estimated parameters based on bootstrap sampling of the
residuals [60]. The result of the fit is summarized in Table 1.
doi:10.1371/journal.pcbi.1000240.g003
Table 1. Model fitting to divergence and diversity dynamics.
Subject AICF (SQF) ds dmax AICS1 (SQS1)A I C S2 (SQS2)
S-P1 2223.5 (6.78) 29.6 [26.7:31.2] 46.2 [45:47.6] 2215.4 (10.9) 2213.1 (10.8)
S-P2 2211.7 (5.16) 55.8 [53.0:58.2] 61.1 [61.0:61.2] 2206.0 (7.92) 2204.0 (7.75)
S-P3 2158.7 (1.44) 26.2 [24.1:28.1] 64.1 [60.4:67.1] 2154.3 (2.61) 2151.3 (2.62)
S-P5 2248.7 (5.47) 2.7 [2.7:2.7] 58.6 [58.6:58.6] 2249.0 (6.44) 2247.7 (6.19)
S-P6 2172.5 (0.67) 0 [0:0] 24.8 [24.8:24.8] 2165.9 (1.37) 2174.1 (0.74)
S-P7 2130.6 (2.21) 69.3 [69.3:69.3] 95.0 [95.0:95.0] 2134.5 (2.63) 2131.4 (2.63)
S-P8 2226.6 (1.25) 37.4 [37.4:37.4] 62.3 [62.3:62.3] 2224.2 (1.74) 2221.6 (1.74)
S-P9 2186.6 (2.85) 26.0 [24.2:28.5] 66.2 [60.5:72.9] 2188.2 (3.43) 2186.2 (3.33)
S-P11 272.5 (1.43) 45.9 [45.9:45.9] 97.6 [97.6:97.6] 269.9 (5.18) 265.7 (5.18)
AIC is Akaike’s information criterion with a second order correction for small sample sizes [61] and SQ is the sum of squared errors; subindex F indicates the full model;
S1 submodel 1; and S2 submodel 2. The parameters dS and dmax are estimated from the full model (Figure 3C), along with 95% CIs (brackets) obtained by bootstrapping
divergence and diversity dynamics 10
3 times. The preferred model has the lowest AIC value.
doi:10.1371/journal.pcbi.1000240.t001
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Since s=t and from Eq. (12),
z 0 ðÞ ~
zs ðÞ
zs ðÞ z 1{zs ðÞ ½  exp {s=dmax ðÞ
: ð15Þ
If we insert Eq. (15) into Eq. (14), we obtain the solution of Eq. (8),
Fz ,t ðÞ ~ e{t=dmaxz 1{e{t=dmax   
z
   dmax: ð16Þ
Then P(d,t), the coefficient of z
d of Eq. (16), is given as a bino-
fmial distribution, Pd ,t ðÞ ~dmax!
.
dmax{d ðÞ !d! ½  1{e{t=dmax    d
e{t=dmax    dmax{d
. Hence, the divergence as a function of time is
measured by the mean of this binomial distribution, Ddivergence~
dmax 1{e{t=dmax   
, and the diversity is given by the standard
deviation of P(d,t), Ddiversity~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dmax 1{e{t=dmax ðÞ e{t=dmax
p
.I n
submodel 2, the divergence first grows linearly and then saturates,
and the diversity first increases and later decreases, which captures
the saturation of divergence and the decline of the diversity at later
stages of HIV-1 infection. The fit of submodel 2 to the divergence
and the diversity dynamics of all 9 subjects is summarized in
Table 1.
Model Comparison
Comparing the full model and the two special cases using
Akaike’s information criterion (AIC) showed that in all the patients
the full model fitted best except for S-P5, S-P7, and S-P9 (Table 1).
Submodels 1 and 2 are interesting to consider because they are
simpler and have analytical solutions. Comparing the two
submodels to each other showed smaller or equal sum of squared
errors for submodel 2 in all subjects except S-P3 (Table 1). One
extra parameter in submodel 2, however, resulted in larger AIC
values than for submodel 1 in all subjects except S-P6. Despite this,
we prefer submodel 2 because it qualitatively captures the decrease
of the diversity at the later stage of HIV-1 infection.
Viral Fitness Effects
We next studied the impact of viral fitness on the dynamics of
the divergence and diversity. Recent ex vivo experimental data have
suggested that the replication rate of viruses sampled at a later
stage of HIV-1 infection is greater than that of viruses at an early
stage of infection [6]. Therefore, we tested how fitness would affect
the viral evolutionary pattern at the sequence level. First, we let
fitness grow linearly as a function of the distance from the founder
strain, i.e., F(d)=f1+f2d, in both submodels 1 and 2. In the range of
f2/f1 from 0 to 10, we do not find any qualitative change in the
patterns of divergence and diversity with time in either submodels
1 or 2 (Figure 4). This showed that an overall increase in fitness
over the disease progression did not have a large effect on the
diversity and divergence dynamics.
Second, we studied the case where the fitness is reduced after a
given distance, F(d)=f for d#dc and F(d)=f9 for d.dc where f9 is
less than f. Here the proportion of offsprings that are mutants is
constant for all viruses, M(d)=0.5. We found that reduced fitness
for viruses with a distance greater than dc reproduced the
observed patterns for divergence and diversity. Figure 5 displays
the calculated dynamics of divergence and diversity when we
reduce the fitness of viruses having a distance greater than 50
mutations to 50% of the fitness of viruses with a distance less than
50 mutations. Although the profile of reduced fitness for the
viruses after a given distance qualitatively explain the common
dynamics of divergence and diversity, the reduction in the fitness
of a virus population at later stages does not seem realistic
considering the observation of increased fitness over the course of
infection [6].
Figure 4. Dynamics of divergence and diversity with linear increase of fitness profile. Divergence (A) and diversity (B) as a function of time
for f(d)=f1+f2d and M(d)=m [submodel 1] for different values of f2/f1. The value of m is chosen as 0.5 and f1=1. The scale factors 300 and 20 for the
divergence and the diversity are introduced to make comparable to the absolute values of measured divergence and diversity. Divergence (C) and
diversity (D) as a function of time for f(d)=f1+f2d and M(d)=12d/dmax for d#dmax and M(d)=0 for d.dmax [submodel 2]. The value of dmax is 40 and
f1=1. The scale factor for the divergence is 500 and that for the diversity is 50.
doi:10.1371/journal.pcbi.1000240.g004
Intrahost HIV-1 Evolution
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viruses may evolve to have a greater level of fitness. This situation
has been described for emerging CXCR4-using viruses later in
disease progression, and was found to correlate with a decline of
diversity [13]. To simulate the outcome of emerging CXCR4-
using viruses, potentially with greater level of fitness since they
have a greater target cell range than CCR5-using viruses by
infecting naı ¨ve CD4+ T-cells, we assigned a greater level of fitness
to a fraction, a, of viruses having a distance larger than a critical
value dc. This process is expressed as
Nd ,t ðÞ ~Fhigh d ðÞ aNd ,t{1 ðÞ 1{Md ðÞ ½ 
zF 1{a ½  Nd ,t{1 ðÞ 1{Md ðÞ ½ 
zFhigh d{1 ðÞ aNd {1,t{1 ðÞ Md {1 ðÞ
zF 1{a ½  Nd {1,t{1 ðÞ Md {1 ðÞ ,
ð17Þ
where Fhigh(d)=Fhigh for d$dc and Fhigh(d)=F otherwise. In this
way, a proportion of viruses, 12a, have fitness F and a proportion
a have fitness Fhigh when d.dc. When d#dc, the fitness is given by
a constant F. We here chose dc=50 mutations for the following
reason. As we will show below, the average overall evolutionary
rate for the 15 studied patients was estimated at approximately
10
23 nucleotide substitutions per site per month. This corresponds
to 0.012 substitutions per site per year. With around 600
nucleotides in the dataset [13], 50 mutations corresponds to the
mutations one expects to accumulate during ,7 years. Thus, we
chose the emergence of CXCR4-using viruses at d=50 from this
calibration since usually X4 viruses appear at later stages of
infection.
Figure 6 plots the dynamics of divergence and diversity by
changing the fraction (a) of X4 viruses that have a 50% increase of
fitness at distance dc=50 mutations. As we increase the value of a,
we observe an increase in divergence, then a transient rapid
increase followed again by the inital slope of linear increase. The
emergence and persistency of X4 viruses in the population leads to
a rapid increase of diversity followed by a decline of diversity.
Then at the final stage, diversity starts to increase again. This
trend is robust to both the amount of fitness increase and the value
of dc. For example, when we chose dc=30, the transient rapid
increases in the divergence and diversity still occur, but were
shifted to 4.2 years. An initial rapid increase both in diversity and
divergence due to the emergence of more fit virus is not
compatible with the in vivo measurements from HIV-1 infected
patients (Figure 3).
Overall, these simulations suggest that the probability profile of
the evolutionary rate, M(d), rather than the fitness profile, F(d), is
the main component in our model that determines realistic within-
patient HIV-1 evolution.
The Rate of Intrapatient Evolution Slows Down over the
Infection
To test the prediction made by the model, i.e., a slowdown of
the evolutionary rate as virus population evolves further from the
founder strain, we calculated the rate of HIV-1 sequence evolution
in consecutive windows over a maximum likelihood (ML) tree
from each patient, starting from the root (see Materials and
Methods). We used longitudinal sequence samples for 15 patients
from two independent studies [13,22]. As an example, Figure 7A
shows the tree describing the HIV-1 evolution in patient S-P6.
Figure 7B shows the resulting evolutionary rate as a function of the
distance from the root for all patients. Interestingly, the rate is not
constant but rather displays a dynamic behavior as HIV-1 evolves.
In agreement with our model predictions, 13 out of the 15 patients
showed a decline of the evolutionary rate as the sequence
population evolved further from its founder strain. The same
dynamic behavior was observed using other window sizes
(D=0.06 for the Shankarappa data and D=0.03 for the Wolinsky
Figure 5. Dynamics of divergence and diversity with fitness
reduction. Dynamics of divergence and diversity when fitness is
reduced to 50% of its original value for d.dc=50 mutations. For d#50,
f=1 and for d.50, f=0.5, and M(d)=0.5 for all d. The saturation of
divergence and the decrease of diversity are observed.
doi:10.1371/journal.pcbi.1000240.g005
Figure 6. Dynamics of divergence and diversity with emer-
gence of X4 viruses. Dynamics of divergence and diversity when
imposing a greater level of fitness for certain types of viruses which
emerge and persist, for example, by acquiring X4 tropism. The X4
viruses appear at d=50 with greater level of fitness Fhigh=1.5 in
comparison to R5 viruses with fitness F=1. The fraction of X4 viruses
out of the total virus population with d$50 is given by a. The rapid
transient increases both in divergence and diversity upon the
emergence of X4 viruses are observed. The scale factor for the
divergence is 500, that for the diversity is 100, and M(d)=0.5 for all d.
doi:10.1371/journal.pcbi.1000240.g006
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robust to the size of the window. In Figure 7B, we also plotted the
evolutionary profile obtained by a fit to the divergence and
diversity dynamics with the full model. The dynamics of the
evolutionary rate calculated from the maximum likelihood tree
was reasonably consistent with that obtained by a model fit to the
divergence and diversity dynamics for each patient.
Sometimes we observed negative evolutionary rates in some
patients when the distance from the root was large, mostly in later
stages of infection (Figure 7B) when the sequence population
hardly evolves any more. As a consequence some sequence
variants may have a smaller distance from the founder
stochastically, and if enough of such variants are detected then
a negative evolutionary rate will be apparent. Also, the apparent
negative rate of evolution may be due to the emergence of less
evolved strains from latent reservoirs at later sampling time
points.
The Rate of Evolution Correlates with CD4+ Count
When the rate of change of the evolutionary rate was compared
to the rate of change of CD4+ T-cell counts (Figure 8A), a
significant correlation (r=0.68, P=0.0014) was observed
(Figure 8B). In the initial interval where CD4+ T-cell counts
were relatively stable (to the left of the dashed bar in Figure 8A),
the evolutionary rate stayed relatively stable too. As CD4+ T-cell
counts decreased and disease progressed in the patients the
evolutionary rate slowed down. However, if one compares the
overall (average) evolutionary rate from the whole study period (as
defined by Eq. (20) in Materials and Methods), not its slope, with
the disease progression rate, no clear correlation was seen
(Figure 8B inset). The overall evolutionary rate of 15 patients
was 10.463.14610
24 substitutions per site per month. Note that
increased or stable viral RNA counts rather than contraction in
viral loads were observed in 7 patients under antiretroviral therapy
in [13]. Thus, the decrease in the rate of evolution seems not to be
associated with the onset of therapy.
We estimated overall synonymous and nonsynonymous evolu-
tionary rates across maximum likelihood trees based on synony-
mous and nonsynonymous changes only using HyPhy [30].
Similar to the overall total substitution rate, we found that neither
synonymous nor nonsynonymous overall evolutionary rates
correlated with the disease progression rate. For progressors with
progression time less than seven years (S-P1, S-P5, S-P6, S-P7, and
S-P8), the average synonymous and nonsynonymous evolutionary
rates were estimated at 6.663.5610
24 and 1265610
24 substi-
tutions per site per month, respectively. For slow disease
progressors with progression time greater than seven years (S-P2,
S-P3, S-P7, S-P9 and SP-11), the average synonymous and
nonsynonymous evolutionary rates were estimated at
6.862.3610
24 and 1364.5610
24 substitutions per site per
month, respectively. Lemey et al. reported lower overall synony-
mous evolutionary rates for these same slow disease progressors
[19]. These contradictory observations may be explained by the
use of different methods in the estimation of the overall
evolutionary rates. While Lemey et al. used codon substitution
models with a Bayesian relaxed clock model, we estimated the
overall synonymous and nonsynonymous evolutionary rates in
separate maximum likelihood trees based on synonymous and
Figure 7. Evolutionary rate as a function of the distance from the root of the maximum likelihood tree of each patient. (A) Maximum
likelihood tree for the viral sequences sampled from patient S-P6 over 6 years [13]. (B) Evolutionary rate as a function of the distance from the root of
the tree for 9 patients from Ref. [13] and 6 patients from Ref. [22] (black lines). The evolutionary rate between sequence i and j is estimated by the
distance difference, dj2di, divided by the sampling time difference, tj2ti. The evolutionary rate at a certain distance from the root d was averaged
over all possible sequence pairs (i, j) within a sliding window. The distance from the root for a particular window d ¯ is the average distance for all the
sequences within that window. The size of the window (D) was 0.09 substitutions per site for S-P1 to S-P11 and 0.02 for W-P1 to W-P6. Error bars
indicate 61 standard deviation. The fitted rate of evolution with the full model to the divergence and diversity dynamics of each patient is depicted
as blue line.
doi:10.1371/journal.pcbi.1000240.g007
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PLoS Computational Biology | www.ploscompbiol.org 7 December 2008 | Volume 4 | Issue 12 | e1000240Figure 8. Dynamic correlation between the rate of HIV-1 evolution and the rate of CD4+ T cell count decline. (A) Evolutionary rate and
CD4+ T-cell level as a function of time relative to seroconversion. Based on the estimation of the evolutionary rate as a function of distance to the root
(Figure 1A), the evolutionary rate is plotted as a function of time (average sampled time point of all the sequences within the window). Error bars
indicate 61 standard deviation. The dynamics of the evolutionary rate is linked to that of the CD4+ T-cell count: While the CD4+ T-cell level is stable,
the evolutionary rate is stable or increasing; the evolutionary rate starts to decrease when the CD4+ T-cell population is depleted. In patients S-P1 to
S-P11, the dashed line indicates the stage when stable CD4+ T-cell count starts to decline. CD4+ T-cell counts were provided by J. Mullins and J.
Learn. Red horizontal line denotes the period of antiretroviral therapy for each patient. (B) Correlation between the slope of CD4+ T cell count and the
slope of the evolutionary rate (r=0.68, P=0.0014). For patients S-P1 to S-P11, the slopes are calculated separately before and after the dashed line.
For W-P1 to W-P6, the slopes are measured over the whole range of the data. Note that the slope of the evolutionary rate for W-P6 is very large due
to tight sampling, and the slope of the CD4+ T cell count is also high in the corresponding time interval, leading to W-P6 becoming an outlier. The
inset shows the average evolutionary rate for different rates of disease progression. Each subject’s average evolutionary rate is measured as the ratio
Intrahost HIV-1 Evolution
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across the trees. A common finding with Lemey et al. is that they
also reported higher nonsynonymous rates (8.263.0610
24) than
synonymous rates (3.861.9610
24). Importantly, although the
overall synonymous evolutionary rate did not correlate with the
disease progression rate in our calculations, we found that both
synonymous and nonsynonymous evolutionary rates decline as
disease progresses in 7 and 8 out of 9 patients in Ref. [13],
respectively (Figure 9).
Recombination Had a Minor Effect on the Evolutionary
Rate
It is well known that HIV-1 recombines during its evolution.
Therefore, we investigated whether recombination could have
obscured our estimates of the evolutionary rates. All patient
populations showed some signal for recombination (Table 2). This
signal was, however, strongly correlated to the degree of
homoplasy (r=0.91). The homoplasy also grew with number of
sequences per patient (R=0.92), and all patients showed
departures from neutral evolution, suggesting stochastic effects as
well as selective environments rather than recombination. Most
importantly, all our ML trees showed a clear time order of how
sequences had been sampled through time (Figure 6), and
additional trees calculated using SplitsTree showed that if
recombination had occurred, then mostly samples taken close in
time had been involved (data not shown). Thus, although difficult
to exactly quantify, recombination had no large effect on our
estimates of the evolutionary rate.
Discussion
The objective of this study was to develop a sequence evolution
model and use it to investigate the relationship between nucleotide
substitutions and disease progression within HIV-1 infected
patients. In particular, we focused on explaining the pattern in
which divergence from the founder increases linearly with time
since infection and then saturates, whereas sequence diversity
increases and ultimately declines. With these aims we developed a
sequence evolution model, fitted the model to the divergence and
diversity dynamics, and investigated two previously described
datasets with rich HIV-1 nucleotide sequence data and CD4+ T-
cell counts over time. Two important conclusions could be drawn
from this study. First, we found that a model in which the survival
of HIV-1 mutants was dictated by the distance from the founder
strain accurately simulated HIV-1 within-patient evolution. This
model could realistically simulate previously observed patterns of
HIV-1 nucleotide sequence diversity and divergence over time by
introducing an initially constant evolutionary rate later followed by
a decline of the rate. Second, the evolutionary rate of HIV-1
within a patient follows the decline of the CD4+ T-cell count over
time. Thus, the evolutionary rate of HIV-1 is not constant over
time, but rather evolves in a dynamic way. This dynamic feature
provides an explanation for previously conflicting observations of
the relationship between the rate of HIV-1 quasispecies evolution
and disease progression.
Three factors may contribute to the decrease of HIV-1’s
evolutionary rate as a function of disease progression. First, a
between the root distance difference and the sampling time difference, averaged over all the sequence pairs in each tree. The error bars indicate 61
standard deviation. Because we rooted our trees using a sequence from the initial time point, and not the clade B consensus as done by Wolinsky et
al. [22], our calculated evolutionary rate differs from theirs. Subjects S-P2, S-P3, S-P7, S-P9, S-P11, W-P5, and W-P6 were classified as slow disease
progressors; S-P1, S-P5, S-P6, S-P7, S-P8, W-P3, and W-P4 as intermediate progessors; and W-P1 and W-P2 as rapid progressors.
doi:10.1371/journal.pcbi.1000240.g008
Figure 9. Dynamics of synonymous and nonsynonymous evolutionary rates. Synonymous (blue lines) and nonsynonymous (black lines)
evolutionary rates as a function of the distance from the root of the tree for 9 patients from Ref. [13]. Synonymous and nonsynonymous rates were
calculated using maximum likelihood trees based on only synonymous and non-synonymous substitutions, respectively, which were inferred using
HyPhy with optimized MG94xREV models [30].
doi:10.1371/journal.pcbi.1000240.g009
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effective viral generation time. At the late stage of infection, the
overall CD4+ T-cell count drops rapidly while viral load increases
[13]. Lymph node immunohistologic alterations in HIV-1 patients
as well as progression to a burned-out lymph node accompanying
end-point lymphocyte depletion in SIV have been reported
[31,32]. Rapid loss of CD4+ T-cells in parallel with viral load
increase might suggest that the proportion of infected cells out of
total CD4+ T cell population is escalated as disease progresses.
Our observation of a positive correlation between the slope of the
evolutionary rate decrease and the slope of the CD4+ T cell count
decline supports this view (Figure 8). Furthermore, the dynamics of
the synonymous substitution rate shows qualitatively a similar
pattern as the dynamics of the total evolutionary rate. Thus it
follows that a decrease of the synonymous rate in most patients
suggests an elongation of the effective viral generation time. In
agreement, it was recently suggested that a slower rate of
synonymous substitutions in patients with slower progression to
AIDS was indicative of longer viral generation times [19]. Second,
a weakening of immune selection pressure, as measured by the
CD4+ T-cell count, may lower the observed evolutionary rate
(Figure 8). Calculating the evolutionary rate in windows across a
tree allowed us to detect a clear correlation between the slope of
the evolutionary rate and the slope of the CD4+ T-cell count.
Hence, deceleration of HIV-1 sequence evolution occurs in
response to decreased immune selection. Not surprisingly, HIV-
1 intrahost sequence evolution follows a principle of quantitative
genetics where the response to selection is directly proportional to
the intensity of selection [33]. If this scenario is operating, then the
nonsynonymous evolutionary rate should decrease with disease
progression. Here, we found that both the nonsynonymous and
synonymous evolutionary rates decreased as disease progressed,
supporting this scenario in addition to the first explanation. Thus,
the decrease in the evolutionary rate at later stage of infection
relates both to amino acid changing and non-changing nucleotide
substitutions. Third, an increase of the viral fitness at later stages of
infection may reduce further accumulation of mutations, finding a
local fitness maximum in the rugged fitness landscape.
A correlation between the decline of diversity and the
emergence of viruses using the CXCR4 coreceptor was reported
in Ref. [13]. The surface expression of the HIV-1 coreceptors
CCR5 and CXCR4 on CD4+ T-cells is differentially expressed on
memory versus naı ¨ve T cells. A chemokine receptor CXCR4 is
expressed on both memory and naive cells, although at greater
levels on naive T-cells [14–17]. It has been reported that naı ¨ve T-
cells are indeed infected and may act as an important viral
reservoir in patients with CXCR4-using viruses [34]. Interestingly,
our modeling revealed that the emergence of a fitter virus
population, using CXCR4, resulted in a rapid increase both in
divergence and diversity followed by the initial slope of linear
increase of divergence and decline of diversity if the probability of
mutations is a constant for all viruses.
Viral escape from neutralizing antibodies [8,12,35] and CD8+
T-cell responses [7,10,36,37] suggest that, within a host, the HIV-
1 sequence population is evolving in a dynamic environment of
immune pressures. One of the selection forces controlling the
evolution of env is escape from antibody neutralization. For
instance, changes in N-linked glycosylation sites in env have been
observed in viruses that escape antibody neutralization [12]. Also,
as shown by an antibody neutralization assay, the virus population
at a specific time point is neutralized more strongly with antibodies
sampled at a later time point [8]. Interestingly, in Table 1 of
reference [8], we observed that antibodies generated at later time
points had a lower neutralizing capacity than those generated
earlier during infection. For example, the maximum strength of
neutralization against virus sampled at month 0 occurred with
antibodies (plasma) sampled at month 12. Virus sampled 6 months
later had a lower neutralizing titer with antibodies sampled at
month 18, and the neutralization strength decreased as disease
progressed. This observation suggests a weakening of the immune
selection pressure during chronic infection. Furthermore, apparent
decrease of CD8+ T-cell levels in HIV-1 chronic infection, as well
Table 2. Polymorphism and population recombination parameters of the studied sequence data.
Sequence Set Number of Sequences SITES gamma SITES c/u SITES Hud4Nc PAUP HI SNAP ds/dn Tajima’s D
S-P1 137 41.494 0.8835 40.016 0.596 1.52 21.0657
S-P2 132 60.153 1.2432 55.695 0.641 0.8 21.1133
S-P3 106 52.052 1.4195 35.629 0.552 0.93 21.0346
S-P5 160 60.342 1.3264 58.403 0.618 1.34 21.4946
S-P6 98 42.382 1.2009 64.24 0.521 1.49 21.5263
S-P7 107 54.818 1.2341 62.637 0.605 0.83 21.0209
S-P8 119 41.083 0.8691 66.185 0.555 1.28 21.4212
S-P9 121 41.108 0.8424 42.343 0.624 0.89 20.9025
S-P11 52 44.522 1.1115 10.185 0.443 1.88 21.6284
W-P1 42 32.392 1.124 365.181 0.287 1.98 22.1969
W-P2 44 23.687 0.7155 71.602 0.222 1.21 22.3736
W-P3 35 19.477 0.7567 28 0.183 0.76 20.1127
W-P4 58 28.297 0.6549 18.005 0.347 1.2 21.9039
W-P5 70 31.498 0.6599 30.479 0.416 0.97 22.0245
W-P6 39 11.117 0.7461 49.973 0.177 2.04 21.0941
SITES gamma is a recombination rate estimate based on [46], and SITES Hud4Nc is based on [62]. SITES c/u is a ratio of the number of recombination events per
mutation, i.e., gamma divided by Theta (4Nu). PAUP HI is the homoplasy index calculated using PAUP* [58]. SNAP ds/dn is the average synonymous/non-synonymous
ratio per patient population calculated using SNAP [41]. Tajima’s D is a measure of departure from a neutral Fisher-Wright model [48].
doi:10.1371/journal.pcbi.1000240.t002
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molecule [38], both imply diminishing CD8+ T-cell responses
over disease progression. Recent observations of selective deple-
tion of high-avidity HIV-1 specific CD8+ T-cells after early HIV-1
infection also implies a lessening of CD8+ T-cell responses [39].
Thus, when the diversifying selection pressure on Env from the
immune system weakens new escape mutations are not beneficial,
and thus the probability to establish new mutations decreases. The
immune pressure selects and removes all virus variants it can
detect, while those escaping are an increasingly diverse set during
chronic infection. When the immune system pressure fails in late
stage disease this pressure to diversify is released and as a result, a
relatively homogeneous sequence population is observed.
Previous studies have suggested an inverse relationship between
disease progression and evolutionary rate based on the observation
of enhanced viral escape under strong immune selection in slow
progressors [2,22]. Also, slower genetic diversification has been
associated with rapid CD4+ T-cell decline [1,20,21,40]. However,
others have reported a positive relationship, suggesting that the
evolutionary rate may be low in nonprogressors due to that
immune selection may suppress emerging virus with potentially
high fitness [23,24]. To resolve these conflicting observations, we
have shown that the rate of HIV-1 env evolution does not remain
constant within a single infected individual, and thus simply
correlating the average rate of evolution with disease progression
may be misleading. Indeed, this may explain the contradictory
results previously published. Thus, rather than using average rates,
we show that the dynamics of the evolutionary rate reflects the rate
of disease progression. In addition to the 13 out of 15 patients in
Figure 7, 3 out of 6 rapid progressors in Ref. [23] show a decrease
in the evolutionary rate when their CD4 cells rapidly deplete,
while 3 non-progressors display a stable evolutionary rate.
Our estimates of the evolutionary rate were based on maximum
likelihood trees calculated using realistic evolutionary substitution
models [2,30,41]. However, these trees implicitly assume that no
recombination has occurred, an assumption that may be violated
by HIV-1 [42–45]. Detecting recombination among closely
related HIV-1 sequences within a patient is difficult due to other
evolutionary mechanisms causing a high degree of homoplasy
(parallel and convergent mutations in different lineages), poten-
tially misleading the analysis. Indeed, most of the patient sequence
sets in this study suggest some degree of intra-population
recombination strongly correlated to the degree of homoplasy in
the dataset (r=0.91). The recombination rates are estimated
under the assumption that just a single mutation has caused each
polymorphism within a group, and that there is no selection [46].
Because these assumptions are violated by HIV-1 env V3 we
evaluated the potential recombination signal. It is well known that
the env V3 region is under positive selection [47], which may lead
to convergent evolution on some residues, explaining some of the
homoplasy. In our data both synonymous/nonsynonymous
mutation ratios and Tajima’s D statistic [48] indicated departures
from neutrality (Table 2). Importantly, previous studies have
shown that recombination and selection rates may confound each
other [49,50]. Also, it is clear that the homoplasy increases as more
sequences are investigated (Table 2). Thus, although difficult to
exactly quantify, part of the detected recombination signal in our
data could be explained by stochastic effects and convergent
evolution. This potential recombination was also analyzed using
SplitsTree [51]. Importantly, that analysis showed that if
recombination had occurred, it mostly involved sequences
collected closely in time. Therefore, the recombination in our
data could only have affected our rate estimates mildly. Most
important, and in agreement with previous publications using
these data (e.g., [13,19]), all our trees displayed a clear time-order
of the samples (Figure 7), which would have been impossible if
recombination had had a strong effect. Similarly, if ancestral
(archival/latent) virus reemerged at later time points, we would
have lost the time-order in the trees. In conclusion, neither
recombination nor reemerging viruses could have had a strong
effect on our rate estimates.
Williamson et al. [18] obtained maximum likelihood estimates
for the mean divergence rate and the divergence stop time in each
Shankarappa patient for the nonsynonymous and synonymous
changes. They observed a strong relationship between the time of
disease progression and the time of divergence stabilization only
for nonsynonymous sites. The evolution profile in [18] corre-
sponds to a constant evolutionary rate before time t followed by
zero evolutionary rate after t. This kind of evolutionary profile can
be imposed in our model by introducing the evolutionary profile
depending on the time rather than the distance from the founder
strain, M(t). Then Eq. (1) is modified as
Nd ,t ðÞ ~Fd ðÞ Nd ,t{1 ðÞ 1{Mt ðÞ ðÞ
zFd {1 ðÞ Nd {1,t{1 ðÞ Mt ðÞ :
ð18Þ
The probability of mutation is a non-zero constant before t and
zero after t, M(t)=m for t#t and M(t)=0 for t.t. We fix the
fitness as a constant, F(d)=f. Figure 10 shows that not only
divergence but also diversity saturates after t. Since the evolution
of the total population stops at t, divergence and diversity stay
constant afterwards. Hence, we can conclude that this alternative
model, where the evolutionary profile depends on time, does not
capture the decline of diversity at later stages of infection.
Similar to HIV-1, one study on intrahost sequence evolution in
hepatitis C virus (HCV) reported that the diversity increased over
time in non-progressors [52]. In contrast, progressors to end-stage
liver disease showed that diversity in the hypervariable region I of
E1/E2 env narrowed over time. We expect that the slowing down
of the rate of HCV evolution also occurs as disease progresses,
resulting in less diversity.
Figure 10. Dynamics of divergence and diversity from the
model when the proportion of mutant offspring is set to zero
after 7 years. Divergence and diversity dynamics calculated under an
alternative model with a constant probability of mutation, 0.5, before
time t followed by zero after t. Here t is chosen as 7 years. Since
evolution of total population stops at t, divergence and diversity stay
constants afterwards.
doi:10.1371/journal.pcbi.1000240.g010
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HIV-1 slows down in 13 of 15 patients from two independent
previous studies [13,22]. The rate of change in the evolutionary
rate is correlated with the slope of CD4+ T-cell decline, dissolving
previously reported conflicting observations of the relationships
between the rate of HIV-1 evolution and disease progression. Our
HIV-1 evolutionary model successfully captured the saturation of
divergence and the decrease of diversity observed in the later
stages of infection. In our model these effects are mostly attributed
to a decrease in the proportion of offspring that are mutants in the
population as the distance from the founder strain increases.
Materials and Methods
Samples and Sequence Data
We analyzed sequence data from two independent studies, the
env C2-V5 region from nine patients [13] and the V3–V5 region
from another six patients [22]. Briefly, sequences from the first
nine patients were collected over their entire disease progression.
The follow-up time varied between 6 to 12 years, at which time
seven had developed AIDS and seven of the patients received
antiretroviral treatment [13]. The other six patients were followed
for 3 to 10 years [22]. Three of these patients received
antiretroviral therapy 2–5 years after infection. All HIV-1
sequences were downloaded from the HIV database (GenBank
Accession numbers AF137629-AF138163, AF138166-AF138263,
AF138305-AF138703 and U35894-U36185).
Reconstruction of Phylogenetic Trees
Sequences were aligned using Se-Al [53]. Trees were created
using enhanced and parallelized versions of fastDNAml and Rates
[54,55], that fit a general-time-reversible substitution model
(RevML) and site rate specific rates (RevRates) in an iterative
way [41,56]. Briefly, a candidate tree topology was created
assuming uniform site rates and an initial random estimate of
nucleotide frequencies and transition rates. RevML proceeds in a
heuristic and piecewise way, starting from a small set of sequences
and building up the tree topology and branch lengths while
making placement decisions that maximize the tree likelihood
score, similar to a stepwise addition algorithm. The resulting tree
then constrains per-site rate optimization of tree likelihood as a
function of global estimates of baseline nucleotide frequency and
transition rates. These estimates are fit using the conjugate
gradient algorithm in the RevRates program. A second RevML
run was then performed using these estimates and in turn another
rate estimation procedure refined from the second tree. A final tree
was estimated using the twice-refined global and local site rates.
Each of the trees in the refinement procedure was independently
estimated from the global and site local rate parameters.
Synonymous and Nonsynonymous Evolutionary Rates
Trees based on synonymous and non-synonymous substitutions,
respectively, were inferred using HyPhy with optimized
MG94xREV models [30]. This model uses a codon-based
substitution model (MG94) that considers substitutions involving
non-stop codons, augmented with a general-time-reversible
nucleotide substitution model (REV) to include the heterogeneity
in nucleotide frequencies and substitution rates [57]. The total
number of changes per codon is decomposed into synonymous
and nonsynonymous changes according to the universal coding
table. Separate synonymous and nonsynonymous rates are then
fitted to each branch of the tree. Prior to model fitting and tree
reconstruction, alignments were codon corrected using the HyPhy
SeqAlignment procedure (with the HIV-1 25% scoring matrix).
Calculation of Divergence and Diversity Dynamics. We
calculated divergence by measuring the maximum likelihood tree
distance from a sequence sampled at time t from a strain found at
the earliest sample time point. Then we averaged all the pairwise
tree distances between the sequences sampled at t and the sequence
sampled at the earliest time point. The diversity was calculated from
the data by averaging pairwise tree distances over all the sequences
obtained at time t. Since the maximum likelihood tree was based on
the nucleotide level, divergence and diversity were also calculated at
a nucleotide level including coding and non-coding changes. The
theoretical curves describing the evolution of divergence and
diversity were computed assuming one time unit in the model
corresponds to one month of evolutionary time.
Estimating Population Polymorphism and
Recombination
We used SITES [46] and SplitsTree [51] to investigate potential
recombination signals in each patient set of sequences, PAUP*
[58] to estimate the amount of homoplasy, SNAP [41] to estimate
average synonymous/non-synonymous rates, and Tajima’s D to
estimate neutral evolution[48].
Calculation of Evolutionary Rate
The rate of evolution was calculated in consecutive windows
over a maximum likelihood (ML) tree from each patient, starting
from the root. The distance to the root for all taxa in each window
[d, d+D] was calculated from the tree (Figure 7A), and the resulting
evolutionary rate was estimated as
ER d
  
~
P dvdi,djvdzD
i,jt i=tj ðÞ
dj{di
    
tj{ti
  
P dvdi,djvdzD
i,jt i=tj ðÞ
1
, ð19Þ
where di(dj) is the distance from the root of sequence i(j) at sampling
time point ti(tj). Here d ¯ is the average distance from the root over
all the sequences within the window, [d, d+D]. The window size
was D=0.09 for the Shankarappa data set and D=0.02 for the
Wolinsky data set. The average evolutionary rate over the entire
sampling period from a patient was calculated as
ER~
P NF
i~1
P Ns
j~iz1 tj=ti ðÞ
dj{di
    
tj{ti
  
P NF
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1
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by averaging the rate of evolution over the sequences in reference
to the founder strains which are sampled at the earliest time point
in each subject. Here, NF is the total number of founder strains and
Ns is the total number of sequences in a patient.
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